Literature DB >> 9146855

The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis.

T Jartti1, T Kaila, K Tahvanainen, T Kuusela, T Vanto, I Välimäki.   

Abstract

AIMS: We wanted to study the effects of a 600 micrograms inhaled salbutamol dose on the cardiovascular and respiratory autonomic nervous regulation in eight children suffering from bronchial asthma.
METHODS: In this randomized, double-blind, placebo-controlled, crossover study we continuously measured electrocardiogram, finger systolic arterial pressure (SAP) and flow-volume spirometry at baseline as well as 20 min and 2 h after the drug inhalation. The R-R interval (the time between successive heart beats) and SAP variabilities were assessed by using spectral analysis. Baroreflex sensitivity was assessed by using cross-spectral analysis.
RESULTS: Salbutamol significantly decreased the total and low frequency (LF) variability of R-R intervals as well as the high frequency (HF) variability of R-R intervals and of SAP. Salbutamol significantly increased the LF/HF ratio of R-R intervals and of SAP, minute ventilation, heart rate and forced pulmonary function in comparison with placebo. The weight of the subjects significantly correlated positively with baroreflex sensitivity and negatively with heart rate after the salbutamol inhalation.
CONCLUSIONS: We conclude that the acute salbutamol inhalation decreases cardiovagal nervous responsiveness, increases sympathetic dominance in the cardiovascular autonomic balance, and has a tendency to decrease baroreflex sensitivity in addition to improved pulmonary function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9146855      PMCID: PMC2042757          DOI: 10.1046/j.1365-2125.1997.00565.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.

Authors:  Leyla Cekici; Arschang Valipour; Robab Kohansal; Otto Chris Burghuber
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

2.  Heart rate variability effects of an agonist or antagonists of the beta-adrenoceptor assessed with scatterplot and sequence analysis.

Authors:  B Silke; J G Riddell
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

Review 3.  Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

Authors:  Vasiliki Petta; Fotis Perlikos; Stelios Loukides; Petros Bakakos; Athanasios Chalkias; Nicoletta Iacovidou; Theodoros Xanthos; Dorothea Tsekoura; Georgios Hillas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects.

Authors:  W M C Mulder; S de Klerk; J J Settels; C J van Boxtel
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

5.  Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.

Authors:  C G Hanratty; B Silke; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

6.  The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure.

Authors:  T T Jartti; T A Kuusela; T J Kaila; K U Tahvanainen; I A Välimäki
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

Review 7.  Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

Authors:  Shelley R Salpeter
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 8.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension.

Authors:  Frank de Vries; Sander Pouwels; Madelon Bracke; Jan-Willem Lammers; Olaf Klungel; Hubert Leufkens; Tjeerd van Staa
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

10.  Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol.

Authors:  Mingxia Yu; Longxia Gao; Yanhua Kong; Yue Yan; Qi Shi; Dongxu Si; Haipeng Bao; Huizhuo Sun; Lei Li; Youlin Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.